Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status

被引:17
作者
Marucha, Jolanta [1 ]
Jurecka, Agnieszka [1 ,2 ]
Syczewska, Malgorzata [3 ]
Rozdzynska-Swiatkowska, Agnieszka [4 ]
Tylki-Szymanska, Anna [1 ]
机构
[1] Childrens Mem Hlth Inst, Metab Dis Clin, PL-04730 Warsaw, Poland
[2] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland
[3] Childrens Mem Hlth Inst, Dept Pediat Phys Therapy, PL-04730 Warsaw, Poland
[4] Childrens Mem Hlth Inst, Anthropometry Lab, PL-04730 Warsaw, Poland
关键词
Activity of daily living; Height; Hunter syndrome; Mucopolysaccharidosis type II; Range of motion; MUCOPOLYSACCHARIDOSIS TYPE-II; ENZYME-REPLACEMENT THERAPY; DISEASE; INVOLVEMENT; LARONIDASE; MECHANISM; HUNTER; SYSTEM; BONE;
D O I
10.1111/j.1651-2227.2011.02522.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: The aims of the study were to assess shoulder range of motion (ROM) in patients with mucopolysaccharidosis type II (MPS II) and to correlate joint mobility with patients height, age and functional status. Methods: Passive ROM and Z-score of height were followed in 29 patients with MPS II (mean age 11.5 years, range 2-29 years) between the years 2005 and 2010. Passive ROM was measured by a goniometer, and height, by a stadiometer. Functional status was assessed by an age-appropriate health assessment questionnaire (HAQ). Results: (i) A strong correlation was observed between patients' age and Z-score of patients' height (R = 0.78, p < 0.001). (ii) A medium correlation was observed between Z-score of patients' height and passive shoulder flexion and abduction (R = 0.697, p < 0.001 and R = 0.63, p < 0.001, respectively). The progression of restriction was slower in attenuated patients. (iii) Restrictions in shoulder flexion and abduction were already observed before the second year of life. (iv) ROM limitations intensified and became more severe with age. (v) Activities of daily living depended on cognitive impairment of patients with MPS II. Conclusion: Range of motion limitations in patients with MPS II correlate with patients' height, increase with patients' age and are more pronounced in a severe form of MPS II.
引用
收藏
页码:E183 / E188
页数:6
相关论文
共 24 条
  • [1] Buckup K, 1995, KLIN TESTS KNOCHEN G, P10
  • [2] MECHANICAL LOADING HISTORY AND SKELETAL BIOLOGY
    CARTER, DR
    [J]. JOURNAL OF BIOMECHANICS, 1987, 20 (11-12) : 1095 - 1109
  • [3] Dega W, 1983, ORTOPEDIA REHABILITA, P17
  • [4] Doorenbosch CAM, 2003, J REHABIL RES DEV, V40, P147
  • [5] Gerhardt J J, 2001, Phys Med Rehabil Clin N Am, V12, P507
  • [6] Impaired elastogenesis in Hurler disease - Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly
    Hinek, A
    Wilson, SE
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) : 925 - 938
  • [7] Enzyme-replacement therapy in mucopolysaccharidosis I.
    Kakkis, ED
    Muenzer, J
    Tiller, GE
    Waber, L
    Belmont, J
    Passage, M
    Izykowski, B
    Phillips, J
    Doroshow, R
    Walot, I
    Hoft, R
    Yu, KT
    Okazaki, S
    Lewis, D
    Lachman, R
    Thompson, JN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) : 182 - 188
  • [8] Orthopedic manifestations in patients with muco polysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey
    Link, Bianca
    Pinto, Louise Lapagesse de Camargo
    Giugliani, Roberto
    Wraith, James Edmond
    Guffon, Nathalie
    Eich, Elke
    Beck, Michael
    [J]. ORTHOPEDIC REVIEWS, 2010, 2 (02) : 56 - 64
  • [9] Recognition and diagnosis of Mucopolysaccharidosis II (Hunter syndrome)
    Martin, Rick
    Beck, Michael
    Eng, Christine
    Giugliani, Roberto
    Harmatz, Paul
    Munoz, Veronica
    Muenzer, Joseph
    [J]. PEDIATRICS, 2008, 121 (02) : E377 - E386
  • [10] Mucopolysaccharidosis type II: skeletal-muscle system involvement
    Morini, Sandra Regina
    Steiner, Carlos Eduardo
    Passos Gerson, Lelia Britto
    [J]. JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 2010, 19 (04): : 313 - 317